Kathryn E. Wengel - 07 Feb 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief TO and Risk Officer
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
07 Feb 2025
Net transactions value
-$3,992,757
Form type
4
Filing time
11 Feb 2025, 19:42:18 UTC
Previous filing
10 Feb 2025
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $3,278,166 +32,762 +40% $100.06 115,028 07 Feb 2025 Direct F1
transaction JNJ Common Stock Tax liability $3,992,757 -26,076 -23% $153.12 88,952 07 Feb 2025 Direct F2
holding JNJ Common Stock 281 07 Feb 2025 By ESOP F3
holding JNJ Common Stock 75 07 Feb 2025 By 401k F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $3,278,166 -32,762 -100% $100.06 0 07 Feb 2025 Common Stock 32,762 $100.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the auto-exercise of options immediately prior to their expiration.
F2 Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.
F3 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F4 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).